Molina Healthcare, Inc. (MOH)

From the record

Molina Healthcare, Inc.'s filings since 2017 show no warning events in the scan: no bankruptcy or receivership notice, no debt default notice, no exchange listing notice, no restatement warning, no auditor change, no material cyber incident and no late-report notice (its current reports).

From the record

Molina Healthcare, Inc.'s 10 filed years say what it did: revenue went from $18 billion in fiscal 2016 to $45 billion in fiscal 2025, up 11% a year; it rose in 7 of 9 years; the deepest fall was 15% from fiscal 2017 to fiscal 2019; net income was positive in 9 of 10 of those years (its annual reports).

From the record

Over the 3 fiscal years to 2025-12-31, Molina Healthcare, Inc.'s diluted share count shrank about 3.3% a year, and dividends and buybacks returned about 100% of its operating cash flow over 3 years (its filed statements). Its officers and directors filed 4 sales and 1 purchase of their own stock on the open market in the year to 2026-10-02, buying about $100 thousand (their Form 4 filings).

From the record

Return on equity: in the fiscal year ended 2025-12-31, Molina Healthcare, Inc. earned about 12 cents of profit for every dollar of shareholders' money, and gross profitability: its products earned about 38 cents per dollar of everything the company owns (revenue less the cost of revenue). Leverage: it owed about 74 cents per dollar of assets, and net share issuance: its share count shrank 8.3% over the year (the filed statements).

From the record

Molina Healthcare, Inc.'s standing among 10 graded names in its industry family: revenue of $45 billion in fiscal 2025 ranks in the bottom 45% by size; a net margin of 1% ranks in the top 45%; revenue growth of 12.4% a year over the last 3 filed years ranks in the bottom 45% (its annual reports).

From the record

Molina Healthcare, Inc.'s leadership, from its insiders' filings and its current reports: the chief executive on the record is Zubretsky, Joseph M (President & CEO, as filed), filing under that title since 2017-11-06, 9 years (top 6% of its family); the 15 officers and directors filing in the last fifteen months have been on the record a median of 8.5 years (top 6%); 4 officer or director changes were reported on Form 8-K since 2023-11-13, against the 15 people in charge now (top 45%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.

From the record

Molina Healthcare, Inc.'s room to grow, from the newest filed statements (fiscal 2025): cash of $4.2 billion against debt of $3.8 billion leaves 3.1% of its assets as net cash, top 45% of its family; cash from operations less capital spending is -1.4% of revenue (bottom 15%); a gross margin of 13.1% (bottom 25%) (its annual report).

From the record

Molina Healthcare, Inc.'s growth drivers, from the filed years to fiscal 2025: revenue grew 12.4% a year over the last three filed years against 11% over all 10, speeding up (top 25% of its family); the newest year grew 11.8% (bottom 25%); capital spending grew 3.5% a year (top 45%) (its annual reports). Molina Healthcare, Inc. tags no split of its revenue by line in the annual report on file, so growth by line cannot be read here; research and capital spending are on the trend.

From the record

Molina Healthcare, Inc.'s newest year against its own record: revenue of $45 billion in fiscal 2025 came in 0.9% below the $46 billion its prior three years' pace pointed to (bottom 45% of its family); net income of $472 million against a prior three-year average of $1.0 billion (bottom 25%); a net margin of 1% against 2.9% before (bottom 25%) (its annual reports).